The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE

B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress

(2013) Md Yuzaiful Md Yusof et al.   Expert Review of Clinical Immunology

Children and adolescents with SLE: not just little adults

(2013) TA Morgan et al.   LUPUS

Lupus nephritis: a 15‐year multi‐centre experience in the UK

(2013) M Hui et al.   LUPUS

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)

(2013) M Witt et al.   LUPUS

Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort

(2012) Louise Watson et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience

(2012) Meryem Can et al.   CLINICAL RHEUMATOLOGY

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study

(2012) A Fernández-Nebro et al.   LUPUS

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts

(2011) Cándido Díaz-Lagares et al.   AUTOIMMUNITY REVIEWS

Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis

(2011) F. Conti et al.   RHEUMATOLOGY

Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis

(2010) Stephen D Marks et al.   ACTA PAEDIATRICA

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Off-label use of rituximab in systemic lupus erythematosus: a systematic review

(2010) Eleanor Murray et al.   CLINICAL RHEUMATOLOGY

Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab

(2010) S. IWATA et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Off-label use of rituximab in a tertiary Queensland hospital

(2009) S. J. Butterly et al.   INTERNAL MEDICINE JOURNAL

Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus

(2008) Hermine I. Brunner et al.   ARTHRITIS AND RHEUMATISM

Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)

(2008) LB Tucker et al.   LUPUS